Sue Jean Lin - Jun 9, 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Keith Klein, as Attorney-in-Fact for Sue-Jean Lin
Stock symbol
ARQT
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 02:07 PM
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +25.7K $0.00 25.7K Jun 9, 2021 Common Stock 25.7K $27.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on each of June 9, 2022, June 9, 2023 and June 9, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date.